CellWell record HH-46931
Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormone
Sun Q; Oltra E; Dijck-Brouwer DAJ; Chillon TS; Seemann P; Asaad S; Demircan K; Espejo-Oltra JA; Sánchez-Fito T; Martín-Martínez E; Minich WB; Muskiet FAJ; Schomburg L
Redox biology · 2023
In plain language
In a European study comparing 167 chronic fatigue syndrome patients with 545 controls, antibodies against the selenium transport protein SELENOP were more prevalent in patients and were linked to lower thyroid hormone activation and lower urinary iodine.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-46931
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.